ETAS, an enzyme-treated asparagus extract, attenuates amyloid beta-induced cellular disorder in PC12 cells

Nat Prod Commun. 2014 Apr;9(4):561-4.

Abstract

One of the pathological characterizations of Alzheimer's disease (AD) is the deposition of amyloid beta peptide (Abeta) in cerebral cortical cells. The deposition of Abeta in neuronal cells leads to an increase in the production of free radicals that are typified by reactive oxygen species (ROS), thereby inducing cell death. A growing body of evidence now suggests that several plant-derived food ingredients are capable of scavenging ROS in mammalian cells. The purpose of the present study was to investigate whether enzyme-treated asparagus extract (ETAS), which is rich in antioxidants, is one of these ingredients. The pre-incubation of differentiated PC 12 cells with ETAS significantly recovered Abeta-induced reduction of cell viability, which was accompanied by reduced levels of ROS. These results suggest that ETAS may be one of the functional food ingredients with anti-oxidative capacity to help prevent AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Asparagus Plant / chemistry*
  • Cell Survival
  • Free Radicals / metabolism
  • L-Lactate Dehydrogenase / metabolism
  • PC12 Cells
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Rats

Substances

  • Amyloid beta-Peptides
  • Free Radicals
  • Plant Extracts
  • L-Lactate Dehydrogenase